关于幻肢运动执行治疗幻肢痛的国际双盲随机对照临床试验的统计分析计划
本文为一项国际双盲随机对照临床试验的正式统计分析计划(版本1.0),该试验比较幻肢运动执行(PME)与幻肢运动想象(PMI)治疗幻肢痛的效果。67名上肢或下肢幻肢痛受试者按2:1随机分配至PME或PMI组,各接受15次干预,主要结局为PME是否比PMI诱导更大的幻肢痛缓解。统计分析计划于2021年8月3日完成。
要点
- 67名幻肢痛受试者按2:1随机分配至PME组或PMI组,各接受15次干预。
- 主要结局为15次PME是否比PMI诱导更大的幻肢痛缓解。
- 次要结局包括疼痛持续时间、其他指标测量的疼痛强度及患者自身印象,并在治疗后1、3、6个月随访评估长期疗效维持。
核心结论
- 本文为PME治疗幻肢痛的国际双盲随机对照临床试验的正式统计分析计划(版本1.0),统计分析计划于2021年8月3日完成。
研究设计与样本
- 国际、双盲、随机对照临床试验,67名上肢或下肢幻肢痛受试者按2:1随机分配至PME组或PMI组。
- 两组受试者均接受15次干预,使用相同设备暴露于相同的VR-AR环境,唯一区别在于执行幻肢运动(PME)还是想象幻肢运动(PMI)。
主要发现
- 主要结局为检查15次PME是否比PMI诱导更大的幻肢痛缓解。
- 次要目标为检查15次PME是否比PMI在幻肢痛相关不同方面(如疼痛持续时间、其他指标测量的疼痛强度及患者自身对治疗效果的印象)提供更大改善。
- 长期疗效维持将通过基线与随访时间点(治疗后1、3、6个月)之间所有变量(主要和次要)的变化来评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Phantom limb pain (PLP) is a detrimental condition that can greatly diminish the quality of life. Purposeful control over the phantom limb activates the affected neural circuitry and leads to dissolution of the pathological relationship linking sensorimotor and pain processing (which gives rise to PLP). An international, double-blind, randomized controlled clinical trial (RCT) on the use of phantom motor execution (PME) as a treatment for PLP is currently undertaken, where PME is compared to an active placebo treatment, namely phantom motor imagery (PMI). METHODS AND DESIGN: Sixty-seven subjects suffering from PLP in upper or lower limbs are randomly assigned in 2:1 ratio to PME or PMI interventions respectively. Subjects allocated to either treatment receive 15 interventions where they are exposed to the same VR-AR environments using the same device. The only difference between interventions is whether phantom movements are performed (PME) or imagined (PMI). RESULTS: The primary outcome of the study is to examine whether 15 sessions of PME can induce a greater PLP relief, compared to PMI. The secondary objectives are to examine whether 15 sessions of PME provide a greater improvement in different aspects related to PLP compared to PMI, such as pain duration, pain intensity as measured by other metrics, and the patient's own impression about the effect of treatment. Long-term retention of treatment benefits will be assessed as change in all the variables (both primary and secondary) between baseline and follow-up timepoints (at 1, 3, and 6 months post-treatment). CONCLUSION: This manuscript serves as the formal statistical analysis plan (version 1.0) for the international, double-blind, randomized controlled clinical trial on the use of PME as a treatment for PLP. The statistical analysis plan was completed on 3 August 2021. TRIAL REGISTRATION: ClinicalTrials.gov NCT03112928 . Registered on April 13, 2017 SAP version: version: 1.0, date: 2021/08/03 Protocol version: This document has been written based on information contained in the study protocol published in Lendaro et al. (BMJ Open 8:e021039, 2018), in July 2018. SAP revisions: Not applicable.
引用
- Lendaro E, Earley EJ, Ortiz-Catalan M, et al. Statistical analysis plan for an international, double-blind, randomized controlled clinical trial on the use of phantom motor execution as a treatment for phantom limb pain. Trials. 2022. PMID: 35152915. doi:10.1186/s13063-021-05962-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。